| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Geriatric Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; the Department of Medicine and the Geriatric Research Education and Clinical Center, University of Maryland, Baltimore, Maryland 00000; the Department of Medicine, University of Virginia, Charlottesville, Virginia 00000; and the Department of Medicine, Harvard University, Boston, Massachusetts 00000
Address all correspondence and requests for reprints to: Dr. Graydon Meneilly, Division of Geriatric Medicine, Department of Medicine, VH&HSC-UBC SiteRoom S139, Vancouver, British Columbia, Canada V6T 2B5.
| Abstract |
|---|
|
|
|---|
We conclude that normal aging is characterized by more disorderly insulin release, a reduction in the amplitude and mass of rapid insulin pulses, and a decreased frequency of ultradian pulses. Whether these alterations in insulin pulsatility contribute directly to the age-related changes in carbohydrate metabolism will require further study.
| Introduction |
|---|
|
|
|---|
Insulin is secreted in a pulsatile fashion. There are rapid, low amplitude pulses that occur every 815 min and ultradian pulses that have a larger amplitude and a periodicity of 60140 min (4, 5). Rapid pulses are important in inhibiting hepatic glucose production (6, 7, 8), whereas ultradian pulses are important in stimulating peripheral glucose disposal (9). Both types of pulses show disruption in disease states characterized by altered glucose metabolism, including impaired glucose tolerance, obesity, and type 2 diabetes (10, 11, 12). The orderliness of insulin release is also quantifiably reduced in nondiabetic relatives of patients with type 2 diabetes (13).
Here we tested the hypothesis that the impairment in carbohydrate metabolism with age is accompanied by alterations in pulsatile insulin secretion and/or the regularity of the insulin release process.
| Subjects and Methods |
|---|
|
|
|---|
These studies were performed in healthy nonobese young and
elderly subjects (Table 1
). Subjects had
a normal history and physical examination, normal laboratory tests,
normal electrocardiogram, and normal glucose tolerance test (glucose
dose, 40 g/m2; National Diabetes Data Group criteria).
|
Experimental protocol
Studies were conducted at the Clinical Research Center at the University of British Columbia. Subjects ate a diet containing at least 150 g carbohydrate/day for 3 days before testing. All subjects underwent two studies, separated by at least 2 weeks. Studies commenced at 0730 h after an overnight fast. In each study, an iv catheter was inserted into a hand vein for sampling of arterialized venous blood (14). In the rapid pulse study, insulin was sampled every 1 min, and glucose was sampled every 2 min for 150 min. In the study to determine ultradian pulses, insulin and glucose were sampled every 10 min for 10 h.
As previously reported (15, 16), all subjects had undergone a 180-min euglycemic insulin clamp (insulin infusion, 40 mU/m2·min) within 1 yr of completing the pulsatile insulin protocol. The glucose infusion rate from 150180 min of the clamp was used as a measure of insulin sensitivity.
VO2 max was determined in all subjects using a bicycle ergometer (15). Waist to hip ratio (WHR) was determined by dividing the abdominal girth at the greatest protuberance by the hip circumference at the greater trochanter (centimeters).
Analytic methods
An aliquot of the sample was used to measure plasma glucose by the glucose oxidase method using a YSI glucose analyzer (Yellow Springs Instruments, Yellow Springs, OH). Blood was placed in prechilled test tubes containing aprotonin (400 kallikrein inhibitor units/mL) and ethylenediamine tetraacetate (1.5 mg/mL) and centrifuged at 4 C. The plasma was stored promptly at -70 C until assay. All samples from each subject were analyzed in the same assay. For the rapid pulsatility analyses, equal numbers of young and old subjects were included in each of two assays. For the ultradian analyses, all samples from all subjects were measured in the same assay. Insulin assays were performed in duplicate using a human insulin kit from Linco Research (St. Louis, MO). This is a very specific and sensitive RIA that has less than 1% cross-reactivity with proinsulin. The interassay coefficient of variation was 11%, and the intraassay coefficient of variation was 6%. The sensitivity was 10 pmol/L.
Pulse analysis
Insulin pulse profiles were analyzed for rapid insulin pulsatility with a multiparameter deconvolution technique (17, 18). This technique quantitatively describes insulin profiles under the following assumptions: 1) a finite number of discrete insulin secretory bursts occurring at specific times, 2) individual secretory burst amplitudes (maximal rates of secretion in a burst), 3) a common half-duration (duration of an algebraically Gaussian secretory pulse at half-maximal amplitude) superimposed on 4) a basal time-invariant increased insulin secretory rate and 5) a nominal insulin half-life of 2.5 min. Parameters were estimated by nonlinear least squares fitting of the multiparameter convolution integral for each insulin time series. A modified Gauss-Newton quadratically convergent iterative technique was employed with an inverse (sample variance) weighting function. Parameters were estimated until their values and the total fitted variance varied by less than 1 part in 100,000. Asymmetric, highly correlated variance spaces were calculated for each parameter by the Monte Carlo support-plane procedure. Optimal peak detection was defined as less than 1 false positive error/10 true pulses and 0 false negative errors/10 true pulses. Optimal peak detection was achieved by use of 95% joint confidence intervals. The following parameters were calculated: secretory burst number (the number of significant secretory pulses per 150 min), interpulse interval (time in minutes separating successive pulses), burst mass (the mass or area of the calculated secretory bursts), amplitude (maximal secretory rate within a pulse), and basal secretion rate. Cluster analysis was used to quantify the longer ultradian insulin rhythms, assuming that significant up- and downstrokes in plasma insulin concentrations denote peaks (19). Incremental peak height, peak frequency, basal (interpeak nadir) insulin concentration, and peak area above interpeak valley insulin concentrations were computed using this program. Threshold criteria included a t statistic of 2.0 and test clusters of 1, with dose-dependent within-assay variance.
In addition to Cluster and deconvolution analysis, the data were evaluated by a recently developed scale- and model-independent statistic, approximate entropy (ApEn) (13, 20, 21, 22, 23), which provides a test for regularity (orderliness) of insulin release that can be compared between groups. This estimate is complementary to pulse and deconvolution analysis. ApEn assigns a single nonnegative number to a time series in which larger values correspond to greater apparent process randomness, and smaller values correspond to more instances of recognizable patterns or consistent features in the data. ApEn measures the logarithmic likelihood that runs of patterns that are similar (within a certain distance, r) for n consecutive observations remain similar on next incremental comparisons. To limit nonstationarity, ApEn was applied after first differencing. A more complete definition of ApEn is contained in recent reports (13, 20, 21, 22, 23).
Cross-correlation analyses between glucose and insulin values were carried out with variable lag (24). r values were transformed to z-scores and compared against a null hypothesis of a zero mean with unit SD.
Data analysis
All data are presented as the mean ± SEM. Differences between young and old subjects were determined by two-sided Students t test for unpaired samples and by repeated measures ANOVA, as appropriate. P values for the cross-correlation analyses were determined using the two-sided Kolmogorov-Smirnov statistic. Correlation coefficients were calculated by the method of least squares. P < 0.05 was considered significant in all analyses.
| Results |
|---|
|
|
|---|
Rapid pulses
Basal insulin secretion, interpulse interval, secretory burst
number, and burst amplitude are shown in Table 2
. Basal insulin secretion was not
different between groups. Although the interpulse interval was longer
in the elderly, and the burst number was reduced, the differences did
not reach statistical significance. Burst amplitude was lower in the
older subjects (P < 0.01). As shown in Fig. 1
, burst mass (proportionate to amplitude
and half-width of the pulse) was lower in the elderly. The ApEn value
was greater in the elderly (Fig. 1
).
|
|
|
There was no correlation between insulin sensitivity measured by the euglycemic clamp and burst mass, amplitude, or entropy. There was also no correlation between WHR or VO2 max and burst mass, amplitude, or entropy.
In the young there was a strongly positive correlation between glucose
and insulin values at 0, 2, 4, and 6 min of lag (Fig. 3
, upper panel). In contrast,
in the elderly the correlation was weaker and restricted to only a
2-min lag (Fig. 3
, lower panel).
|
Cluster analysis was used to quantify ultradian peaks in plasma
insulin concentrations (Table 3
). Eight
of nine older subjects underwent the ultradian study. Basal (interpeak
nadir) plasma insulin concentrations were similar. Peak number was
reduced in the aged subjects (P < 0.05). As shown in
Fig. 4
, interpeak interval was longer in
the old subjects. Peak area, height, and ApEn values were not
significantly different between groups.
|
|
|
There was a significant correlation between insulin sensitivity as measured by the euglycemic clamp and peak number (r = 0.67; P < 0.01) and interpeak interval (r = -0.66; P < 0.01). There was also a significant correlation between VO2 max and peak number (r = 0.53; P < 0.05) and interpeak interval (r = -0.50; P < 0.05). There was no correlation between WHR and peak number or interpeak interval.
Significant cross-correlations were found at all lag times from -60 to 60 min in both age groups.
| Discussion |
|---|
|
|
|---|
Several studies have found that rapid insulin pulses inhibit hepatic glucose output (HGO), but do not significantly alter peripheral glucose utilization (6, 7, 8). Further evidence that rapid pulses are more important in regulating HGO than peripheral glucose disposal is that we found no correlation between insulin-mediated glucose disposal (as measured by the euglycemic clamp) and the alteration in rapid pulse parameters. In addition, rapid pulses are of considerably higher amplitude in the portal vein than in the peripheral circulation, and their extrahepatic effects on glucose utilization would be small. Given that postprandial suppression of HGO is reduced with age (1), we postulate that the reduced amplitude of rapid insulin pulses observed here in older subjects may contribute to the age-related alterations in the regulation of HGO. Further studies involving replacement of normal insulin pulses in the elderly and measurement of glucose turnover with tracer techniques will be required to test this hypothesis.
The orderliness of the insulin release process may be regulated by the neural network in the pancreas (28, 29, 30, 31), which coordinates secretion by thousands of islets. Our quantification of the orderliness of insulin secretion via an ApEn statistic indicates that the regularity of insulin release is reduced with age. This new finding is consistent with an alteration in neural regulation of pancreatic function in the elderly. We recently reported that pancreatic polypeptide responses to hypoglycemia are impaired in the elderly (32). This response is mediated by the vagus nerve. Thus, a deficient pancreatic polypeptide response to hypoglycemia in healthy elderly subjects is in accord with a postulated alteration of neural regulation of the pancreatic islets. In addition, it has recently been demonstrated that the orderliness of GH, LH, and testosterone secretion and the synchrony between LH and testosterone release as well as that between ACTH and cortisol release are impaired with normal aging (21, 33, 34), suggesting a more widespread alteration in the neural and/or feedback regulation of hormone secretion with age. The decrease in insulin pulse amplitude and mass that we report is consistent with previous studies, which have found similar reductions with aging in the pulsatile release of other hormones under basal conditions, including GH, TSH, and cortisol (33, 35, 36).
Factors that could explain differences between age groups in rapid insulin pulsatility include aerobic capacity and body composition, as our elderly subjects had a lower VO2 max, a higher BMI, and a greater WHR. It is unlikely that the increased fitness of our young subjects explains the difference in rapid insulin pulses we report, because there was no correlation between VO2 max and pulse parameters in these studies. In addition, increased physical fitness is accompanied by reduced spontaneous insulin burst amplitude in young subjects (18). The higher aerobic capacity of our young subjects would minimize differences between young and old. It is unlikely that the abdominal obesity in the elderly explains our results, as there was no correlation between WHR and pulse parameters. Abdominal obesity in younger subjects has been shown not to alter the frequency of rapid insulin pulses, but to decrease their relative and increase their absolute amplitude (37). The abdominal obesity (as measured by WHR) observed in our elderly subjects would serve to increase incremental burst amplitude and again minimize differences between the age groups. In addition, when we compared young and old subjects matched for BMI, the differences in pulse parameters between groups remained. Thus, we believe that the changes we observed in rapid insulin pulses are probably due to aging per se and not solely to differences in body composition or physical fitness between age groups.
Circa-sesquihoral (ultradian) pulses of insulin release are present during fasting and nutrient ingestion (5, 28, 38, 39, 40, 41, 42, 43). In patients with impaired glucose tolerance and noninsulin-dependent diabetes mellitus, the amplitude is reduced, and regularity of the pulses is altered, but the frequency of insulin pulses is maintained (10, 12, 38, 44). In abdominal obesity, the frequency of pulses is unchanged, the absolute amplitude is increased, and the relative amplitude is diminished (5, 37). We found that the amplitude of ultradian insulin pulses was similar in young and old subjects, but their frequency was reduced in the aged. Previous studies have not evaluated ultradian insulin pulses during fasting in healthy elderly individuals. Scheen et al. administered glucose by continuous infusion for 53 h to eight moderately obese elderly subjects and compared the results to those in eight weight-matched young controls (45). They found no differences in insulin pulse frequency or amplitude, but observed a decreased responsiveness of insulin secretion to ultradian oscillations in plasma glucose in the elderly. Their results are consistent with ours with regard to pulse amplitude. The reason for the decrease in pulse frequency is unclear. Potential plausible explanations are that their elderly subjects were younger than ours and relatively more obese, their samples were obtained less frequently (every 20 min vs. every 10 min), and a different methodology was used to analyze insulin pulses. Studies in the dog using both deconvolution and Cluster analysis indicate that sampling frequency is a critical determinant of pulse detection (17). Moreover, glucose was infused by Scheen et al. (45), which in animals increases the frequency of insulin pulses (46).
We believe that our results regarding ultradian pulsatility also are likely due to aging rather than to differences in body composition between the two age groups, as there was no correlation between insulin pulse parameters and WHR. Differences between young and old subjects in pulse parameters were maintained when we matched subjects for BMI. In addition, in middle-aged subjects with abdominal obesity, ultradian pulse frequency was not altered (37). Of interest, there was a significant correlation between VO2 max and ultradian insulin pulse frequency. To our knowledge, no previous studies have evaluated the association of physical fitness with specific ultradian insulin pulse features.
To our knowledge, this is the first clinical study to report alterations in the frequency of ultradian insulin pulses in conditions characterized by abnormal carbohydrate metabolism. If ultradian pulses are important in regulating glucose disposal (9), and normal aging is characterized by resistance to insulin-mediated glucose disposal (2, 3), then alterations in ultradian insulin pulses may be relevant to the insulin resistance of aging. Support for this theory is the correlation we found between pulse frequency and insulin sensitivity measured by the euglycemic clamp. However, to prove this hypothesis, studies will have to be conducted with replacement of normal insulin pulses in the elderly and measurement of glucose turnover by tracer techniques.
We observed a reduction in the frequency of ultradian, but not rapid, insulin pulses in elderly subjects. Rapid pulses are regulated putatively by a local neural activity within the pancreas, whereas insulin/glucose feedback probably plays an important role in regulating ultradian insulin oscillations (28). Accordingly, age-related alterations in insulin dynamics are mechanistically distinct. It is entirely possible that the alterations we report would be different during stimulation of insulin secretion by glucose, amino acids, or a meal. This area should be the subject of further study.
In conclusion, we found that rapid and ultradian insulin pulses are altered with normal aging. The pathophysiological relationship of these disturbances in the dynamics of insulin release in elderly subjects to the known alterations in carbohydrate metabolism in older individuals will ultimately require further investigation.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 24, 1996.
Revised August 6, 1997.
Accepted September 15, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. R. Kelly, L. M. Brooks, T. P. J. Solomon, S. R. Kashyap, V. B. O'Leary, and J. P. Kirwan The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1269 - E1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, D. M. Keenan, and S. M. Pincus Motivations and Methods for Analyzing Pulsatile Hormone Secretion Endocr. Rev., December 1, 2008; 29(7): 823 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Gambert and S. Pinkstaff Emerging Epidemic: Diabetes in Older Adults: Demography, Economic Impact, and Pathophysiology Diabetes Spectr, October 1, 2006; 19(4): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Ihm, I. Matsumoto, T. Sawada, M. Nakano, H. J. Zhang, J. D. Ansite, D. E.R. Sutherland, and B. J. Hering Effect of donor age on function of isolated human islets. Diabetes, May 1, 2006; 55(5): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Meneilly, J. D. Veldhuis, and D. Elahi Deconvolution Analysis of Rapid Insulin Pulses before and after Six Weeks of Continuous Subcutaneous Administration of Glucagon-Like Peptide-1 in Elderly Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6251 - 6256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Basu, E. Breda, A. L. Oberg, C. C. Powell, C. Dalla Man, A. Basu, J. L. Vittone, G. G. Klee, P. Arora, M. D. Jensen, et al. Mechanisms of the Age-Associated Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, Action, and Clearance Diabetes, July 1, 2003; 52(7): 1738 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chang and J. B. Halter Aging and insulin secretion Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E7 - E12. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Porksen, T. Grofte, J. Greisen, A. Mengel, C. Juhl, J. D. Veldhuis, O. Schmitz, M. Rossle, and H. Vilstrup Human insulin release processes measured by intraportal sampling Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E695 - E702. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes Diabetes, February 1, 2002; 51(90001): S245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Gill, V. Tillmann, J. D. Veldhuis, and P. E. Clayton Patterns of GH Output and Their Synchrony with Short-Term Height Increments Influence Stature and Growth Performance in Normal Children J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5860 - 5863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, A. Iranmanesh, D. Naftolowitz, N. Tatham, F. Cassidy, and B. J. Carroll Corticotropin Secretory Dynamics in Humans under Low Glucocorticoid Feedback J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5554 - 5563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korosi, C. H.S. McIntosh, R. A. Pederson, H.-U. Demuth, J. F. Habener, R. Gingerich, J. M. Egan, D. Elahi, and G. S. Meneilly Effect of Aging and Diabetes on the Enteroinsular Axis J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2001; 56(9): M575 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, M. Straume, A. Iranmanesh, T. Mulligan, C. Jaffe, A. Barkan, M. L. Johnson, and S. Pincus Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R721 - R729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, S. M. Pincus, R. Mitamura, K. Yano, N. Suzuki, Y. Ito, Y. Makita, and A. Okuno Developmentally Delimited Emergence of More Orderly Luteinizing Hormone and Testosterone Secretion during Late Prepuberty in Boys J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 80 - 89. [Abstract] [Full Text] |
||||
![]() |
M. Bergendahl, A. Iranmanesh, C. Pastor, W. S. Evans, and J. D. Veldhuis Homeostatic Joint Amplification of Pulsatile and 24-Hour Rhythmic Cortisol Secretion by Fasting Stress in Midluteal Phase Women: Concurrent Disruption of Cortisol-Growth Hormone, Cortisol-Luteinizing Hormone, and Cortisol-Leptin Synchrony J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4028 - 4035. [Abstract] [Full Text] |
||||
![]() |
S. M. Pincus, J. D. Veldhuis, and A. D. Rogol Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E417 - E424. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bergendahl, A. Iranmanesh, T. Mulligan, and J. D. Veldhuis Impact of Age on Cortisol Secretory Dynamics Basally and as Driven by Nutrient-Withdrawal Stress J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2203 - 2214. [Abstract] [Full Text] |
||||
![]() |
J. D. Veldhuis, A. Iranmanesh, M. Godschalk, and T. Mulligan Older Men Manifest Multifold Synchrony Disruption of Reproductive Neurohormone Outflow J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1477 - 1486. [Abstract] [Full Text] |
||||
![]() |
J. A. Morais, R. Ross, R. Gougeon, P. B. Pencharz, P. J. H. Jones, and E. B. Marliss Distribution of Protein Turnover Changes with Age in Humans as Assessed by Whole-Body Magnetic Resonance Image Analysis to Quantify Tissue Volumes J. Nutr., April 1, 2000; 130(4): 784 - 791. [Abstract] [Full Text] |
||||
![]() |
M. Bergendahl, A. Iranmanesh, W. S. Evans, and J. D. Veldhuis Short-Term Fasting Selectively Suppresses Leptin Pulse Mass and 24-Hour Rhythmic Leptin Release in Healthy Midluteal Phase Women without Disturbing Leptin Pulse Frequency or Its Entropy Control (Pattern Orderliness) J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 207 - 213. [Abstract] [Full Text] |
||||
![]() |
S. M. Pincus, M. L. Hartman, F. Roelfsema, M. O. Thorner, and J. D. Veldhuis Hormone pulsatility discrimination via coarse and short time sampling Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E948 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, Ali Iranmanesh, Thomas Mulligan, and Steven M. Pincus Disruption of the Young-Adult Synchrony between Luteinizing Hormone Release and Oscillations in Follicle-Stimulating Hormone, Prolactin, and Nocturnal Penile Tumescence (NPT) in Healthy Older Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3498 - 3505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Meneilly, J. D. Veldhuis, and D. Elahi Disruption of the Pulsatile and Entropic Modes of Insulin Release during an Unvarying Glucose Stimulus in Elderly Individuals J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1938 - 1943. [Abstract] [Full Text] |
||||
![]() |
P. Iozzo, H. Beck-Nielsen, M. Laakso, U. Smith, H. Yki-Järvinen, and E. Ferrannini Independent Influence of Age on Basal Insulin Secretion in Nondiabetic Humans J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 863 - 868. [Abstract] [Full Text] |
||||
![]() |
M. Bergendahl, W. S. Evans, C. Pastor, A. Patel, A. Iranmanesh, and J. D. Veldhuis Short-Term Fasting Suppresses Leptin and (Conversely) Activates Disorderly Growth Hormone Secretion in Midluteal Phase Women--A Clinical Research Center Study J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 883 - 894. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |